Hoechst 33342-induced apoptosis is associated with intracellular accumulation of E2F-1 protein in BC3H-1 myocytes and HL-60 cells

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 1, 2001, Pages 99-104

  Zhang, X ^a   Kiechle, F L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; HOE 33342; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; DNA FOOTPRINTING; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MUSCLE CELL; PROTEIN BINDING; SEQUENCE ANALYSIS;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BENZIMIDAZOLES; BINDING SITES; BISBENZIMIDE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA; DNA TOPOISOMERASES, TYPE I; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HL-60 CELLS; HUMANS; MICE; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0035137402     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Diverse molecular provocation of programmed cell death
2. Apoptosis: A brief review
3. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control
4. Transcriptional control by E2F
5. The retinoblastoma protein and cell cycle control
6. E2F-1 functions in mice to promote apoptosis and suppress proliferation
7. Tumor induction and tissue atrophy in mice lacking E2F-1
8. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells
10. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2
11. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo
12. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require pS3
13. p53 and E2F-1 cooperate to mediate apoptosis
14. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
15. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
16. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
17. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members
18. Cloning and characterization of human DP2, a novel dimerization partner of E2F
19. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene
20. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis
21. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis
22. An E2F dominant negative mutant blocks E1A induced cell cycle progression
23. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
24. Hoechst 33342 induces apoptosis and alters TATA box binding protein/DNA complexes in nuclei from BC3H-1 myocytes
25. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo
26. Mechanism of Hoechst 33342-induced apoptosis in BC3H-1 myocytes
27. Hoechst 33342 induces apoptosis and alters TATA box binding protein/DNA complexes in nuclei from HL-60 cells
28. Assessment of mitochondrial function in cells grown in tissue culture
29. Sequencing end-labeled DNA with base-specific chemical cleavages
30. A cDNA encoding a pBR-binding protein with properties of the transcription factor E2F
31. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification
32. Flow cytometric ratio analysis of the Hoechst 33342 emission spectrum: Multiparametric characterization of apoptotic lymphocytes
33. A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells
34. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations
35. DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors
36. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA
37. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities
38. Hoechst 33342-induced apoptosis in BC3H-1 myocytes
39. Induction of apoptosis in endothelial cells treated with cholesterol oxides
40. Hoechst 33342 induces apoptosis in hepatoma cells and inhibits topoisomerase I in vivo
41. Hoechst 33342 induces apoptosis, inhibits topoisomerase I and alters TATA box binding protein/DNA complexes in HT-144 melanoma cells
42. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression
43. Premature p34cdc2 activation required for apoptosis
44. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
45. Apoptotic cell death induced by c-myc is inhibited by bcl-2
46. Participation of cyclin A in Myc-induced apoptosis
47. Induction of apoptosis in fibroblasts by c-myc protein
48. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
49. Death receptors: Signaling and modulation